Cannabinoid Encyclopedia

Focused research review

TRPV3 cannabinoid target: what the research says

What evidence connects cannabinoids or endocannabinoids with TRPV3 channel activity, binding, or signaling?

Updated July 2026 12 research sources Mostly early-stage research

The short answer

What is the bottom line?

Research has examined TRPV3 cannabinoid target. This page brings together 2 human-study sources, 3 research reviews, and 6 lab, animal, or mechanism sources. Most of the current evidence is preclinical or focused on biological mechanisms. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about TRPV3 cannabinoid target.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on TRPV3 cannabinoid target covers TRPV3; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about TRPV3 cannabinoid target

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly mechanism-focused

TRPV3

This part of the literature focuses on TRPV3. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

2 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

3 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

6 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

Another 1 of 12 research source could not be placed cleanly into those three groups from the recorded study details.

What these studies actually looked at

The research on TRPV3 cannabinoid target is not one kind of study. This source set includes 4 animal studies, 2 narrative or expert reviews, 1 cell or laboratory study, and 1 systematic review or meta-analysis. 3

The recorded populations or models include animal models (4 sources) and people or patients (4 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is tRPV3 channel activity, binding, signaling, dermatology-relevant mechanism, or pharmacology (12 sources). Closely related outcome names can still describe different measurements. 5

The TRPV3 cannabinoid target source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

systematic review or meta-analysis

A Systematic Review of Plant-Derived Natural Compounds for Anxiety Disorders.

On this page, this source examines Cannabinoids activity involving TRPV3. 1

Study type
systematic review or meta-analysis
Population or model
people or patients
Outcome focus
tRPV3 channel activity, binding, signaling, dermatology-relevant mechanism, or pharmacology
Evidence stage
evidence still limited

animal study

Pure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9-tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages.

On this page, this source examines THCV activity involving TRPV3. 2

Study type
animal study
Population or model
animal models
Outcome focus
tRPV3 channel activity, binding, signaling, dermatology-relevant mechanism, or pharmacology
Evidence stage
mechanism-focused research

narrative or expert review

Cannabinoid Ligands Targeting TRP Channels.

On this page, this source examines THC activity involving TRPV3. 3

Study type
narrative or expert review
Outcome focus
tRPV3 channel activity, binding, signaling, dermatology-relevant mechanism, or pharmacology
Evidence stage
evidence still limited

narrative or expert review

Pharmacogenetics of new analgesics.

On this page, this source examines Cannabinoids activity involving TRPV3. 4

Study type
narrative or expert review
Population or model
people or patients
Outcome focus
tRPV3 channel activity, binding, signaling, dermatology-relevant mechanism, or pharmacology
Evidence stage
evidence still limited

animal study

Cannabidiol sensitizes TRPV2 channels to activation by 2-APB.

On this page, this source examines CBD activity involving TRPV3. 5

Study type
animal study
Population or model
animal models
Outcome focus
tRPV3 channel activity, binding, signaling, dermatology-relevant mechanism, or pharmacology
Evidence stage
mechanism-focused research

Safety and limits

What should readers keep in mind?

Research on TRPV3 cannabinoid target should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence connects cannabinoids or endocannabinoids with TRPV3 channel activity, binding, or signaling?

Relevant research is collected here. Most of the current evidence is preclinical or focused on biological mechanisms. 7

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 8

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    A Systematic Review of Plant-Derived Natural Compounds for Anxiety Disorders. systematic review or meta-analysis; evidence still limited PubMed 26845556 DOI 10.2174/1568026616666160204121039
  2. 2
    Pure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9-tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages. animal study; mechanism-focused research PubMed 27498155 DOI 10.1016/j.phrs.2016.07.045
  3. 3
    Cannabinoid Ligands Targeting TRP Channels. narrative or expert review; evidence still limited PubMed 30697147 DOI 10.3389/fnmol.2018.00487
  4. 4
    Pharmacogenetics of new analgesics. narrative or expert review; evidence still limited PubMed 20942817 DOI 10.1111/j.1476-5381.2010.01074.x
  5. 5
    Cannabidiol sensitizes TRPV2 channels to activation by 2-APB. animal study; mechanism-focused research PubMed 37199723 DOI 10.7554/elife.86166
  6. 6
    Cannabidiol sensitizes TRPV2 channels to activation by 2-APB. animal study; mechanism-focused research PubMed 36747846 DOI 10.1101/2023.01.27.525817
  7. 7
    Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. animal study; mechanism-focused research PubMed 21726418 DOI 10.1111/j.1748-1716.2011.02338.x
  8. 8
    An Analysis of the Putative CBD Binding Site in the Ionotropic Cannabinoid Receptors. evidence still limited PubMed 33362478 DOI 10.3389/fncel.2020.615811
  9. 9
    Exploring Cannabidiol-TRPV3 Mediated Biological Activities-Findings From Molecular Docking, Simulation and Proteins Network Interactions. mechanism-focused research PubMed 40025806 DOI 10.1002/cbdv.202403494
  10. 10
    Human podocytes express functional thermosensitive TRPV channels. cell or laboratory study; mechanism-focused research PubMed 28945920 DOI 10.1111/bph.14052
  11. 11
    The Impact of a Quinone Scaffold on Thermo-TRPs Modulation by Dimethylheptyl Phytocannabinoids. mechanism-focused research PubMed 40141324 DOI 10.3390/ijms26062682
  12. 12
    TRPV3 activation by different agonists accompanied by lipid dissociation from the vanilloid site. mechanism-focused research PubMed 38691614 DOI 10.1126/sciadv.adn2453
See all 12 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Cannabinoid Ligands Targeting TRP Channels. narrative or expert review; evidence still limited / 1 linked research note PubMed 30697147
  2. An Analysis of the Putative CBD Binding Site in the Ionotropic Cannabinoid Receptors. evidence still limited / 1 linked research note PubMed 33362478
  3. Pure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9-tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages. animal study; mechanism-focused research / 1 linked research note PubMed 27498155
  4. TRPV3 activation by different agonists accompanied by lipid dissociation from the vanilloid site. mechanism-focused research / 1 linked research note PubMed 38691614
  5. Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. animal study; mechanism-focused research / 1 linked research note PubMed 21726418
  6. Cannabidiol sensitizes TRPV2 channels to activation by 2-APB. animal study; mechanism-focused research / 1 linked research note PubMed 37199723
  7. Cannabidiol sensitizes TRPV2 channels to activation by 2-APB. animal study; mechanism-focused research / 1 linked research note PubMed 36747846
  8. Pharmacogenetics of new analgesics. narrative or expert review; evidence still limited / 1 linked research note PubMed 20942817
  9. Human podocytes express functional thermosensitive TRPV channels. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 28945920
  10. Exploring Cannabidiol-TRPV3 Mediated Biological Activities-Findings From Molecular Docking, Simulation and Proteins Network Interactions. mechanism-focused research / 1 linked research note PubMed 40025806
  11. A Systematic Review of Plant-Derived Natural Compounds for Anxiety Disorders. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 26845556
  12. The Impact of a Quinone Scaffold on Thermo-TRPs Modulation by Dimethylheptyl Phytocannabinoids. mechanism-focused research / 1 linked research note PubMed 40141324